← Back to Search

Behavioral Intervention

Online ACT Program for Chronic Health Conditions

N/A

Waitlist Available

Led By Michael E Levin, PhD

Research Sponsored by Utah State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Self-report having had the chronic health condition for ≥ 3 months

≥ 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, post-assessment (6 weeks after baseline), follow-up (10 weeks after baseline)

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to evaluate a new online program for adults with chronic health conditions (CHCs) to improve their quality of life. The program is based on Acceptance and Commitment Therapy (ACT),

Who is the study for?

This trial is for adults with chronic health conditions who are looking to improve their quality of life. Participants should be interested in an online self-help program and willing to provide feedback. Specific eligibility criteria were not provided, so it's best to contact the study organizers for detailed requirements.

What is being tested?

The trial is testing a new online Acceptance and Commitment Training (ACT) program designed for individuals with various chronic health conditions. The aim is to see if this 6-session, self-guided ACT course can enhance participants' wellbeing and quality of life.

What are the potential side effects?

Since the intervention involves an online training program focused on mental well-being, there may not be physical side effects like those associated with medication or medical procedures. However, emotional discomfort could arise as participants work through personal challenges during the course.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had my chronic condition for 3 months or more.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, post-assessment (6 weeks after baseline), follow-up (10 weeks after baseline)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, post-assessment (6 weeks after baseline), follow-up (10 weeks after baseline)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-assessment (6 weeks after baseline), follow-up (10 weeks after baseline) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Mental Health Continuum - Short Form (MHC-SF; to assess positive mental health)

Secondary study objectives

CompACT (to assess psychological flexibility)

Depression, Anxiety and Stress Scale (DASS-21)

Program satisfaction (Responses to a series of single item Likert-scale items about satisfaction with the intervention)

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: TreatmentExperimental Treatment1 Intervention

Following random assignment to the condition after completing baseline assessment, participants will be instructed to complete the ACT Guide for Chronic Health Conditions program over the next 6 weeks.

Group II: Waitlist ControlActive Control1 Intervention

Following random assignment to the condition after completing baseline assessment, participants will be instructed to wait to receive the intervention after a period of 10 weeks (this accounts for the 6 weeks that treatment condition participants are given to complete the program, plus the 4 interim between post-assessment and follow-up.

0 / 2Eligibility criteria met